- Clinical Interests
- Diseases of the ear and lateral cranial base
- Hearing loss
- Cochlear implants
- Auditory brainstem implants
- Facial paralysis and deafness related to NF2
- Medical Education
- MD, University of Utah School of Medicine
- Residency, University of Iowa Hospitals & Clinics
- Fellowship, The Ear Foundation
- Board Certifications
- Otology & Neurotology
- Boston: Massachusetts Eye and Ear Infirmary
- Insurances Accepted
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Harvard Pilgrim Health Plan - other
- Senior Whole Health
- Tufts Health Plan
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
Dr. Welling's clinical interests involve caring for patients with diseases of the ear and lateral cranial base. More specifically, he focuses on hearing loss, cochlear implants, auditory brainstem implants, as well as facial paralysis and deafness related to Neurofibromatosis type 2 (NF2)-associated tumors. Dr. Welling's research efforts primarily focus on NF2-associated vestibular schwannomas.
- Research Summary
Dr. Welling's clinical and research interests focus primarily on NF2-associated vestibular schwannomas and the hearing loss, disequilibrium and facial paralysis that may result from the disease. In 1996, Dr. Welling and his collaborators published the promoter of the NF2 gene and documented genotype-phenotype correlations. This work was awarded the Edmund Prince Fowler Award from The Triological Society for the best basic science thesis. Later work using cDNA microarray analysis to identify involved pathways in tumor formation was awarded the Nicholas Torok Award from the American Neurotologic Society. In conjunction with these studies, Dr. Welling leads five targeted clinical trials for NF2-related tumors based upon his in vitro work and the work of many others.
Additional research interests for Dr. Welling include the use of regenerative growth factors for the promotion of healing of tympanic membrane (TM) perforations, as well as the use of virtual simulation in otologic surgery training. The utility of regenerative growth factors in healing TM perforations has been shown in vivo. If found to be successful, the approach could offer an alternative to surgical repair (and greatly reduce associated cost and surgical morbidity). Dr. Welling's work in the area of otologic surgery training has led to a validated model for temporal bone dissection.
243 Charles Street
Boston, MA 02114 - 3002